跳至主要内容
临床试验/EUCTR2012-003412-31-BE
EUCTR2012-003412-31-BE进行中(未招募)不适用

Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients. - BROVALE

CUB - Hôpital Erasme0 个研究点开始时间: 2012年9月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Woman 18-40 years old with breast cancer
  • -Referred for fertility preservation at least 13 days before starting chemotherapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 54
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • -Breast cancer TxNxM1
  • -Premature ovarian failure
  • -Poor ovarian function FSH>20mIU/ml
  • -Surgical contraindication

研究者

发起方
CUB - Hôpital Erasme

相似试验